Table 1.
Participants Enrolled | TDF/FTC (n=304) | CAB-LA (n=266) |
---|---|---|
n (%) | n (%) | |
Self–identification | ||
Female | 43 (14.1) | 47 (17.7) |
Transgender male | 0 (0.0) | 0 (0.0) |
Transgender female | 213 (70.1) | 187 (70.3) |
Gender queer | 18 (5.9) | 14 (5.3) |
Gender variant or gender non-confirming | 27 (8.9) | 16 (6.0) |
Other self-identification | 3 (1.0) | 2 (0.8) |
Prefer not to answer | 0 (0.0) | 0 (0.0) |
Age | ||
18-29 | 244 (80.3) | 227 (85.3) |
30-39 | 42 (13.8) | 29 (10.9) |
40+ | 18 (6.0) | 10 (3.7) |
Median (IQR) | 23 (21, 28) | 23 (21, 27) |
Geographic Region | ||
US | 71 (23.4) | 54 (20.3) |
Latin America | 113 (37.2) | 92 (34.6) |
Asia | 110 (36.2) | 115 (43.2) |
Africa | 10 (3.3) | 5 (1.9) |
Education | ||
Secondary or lower | 143 (47.1) | 125 (47.0) |
Technical Training | 22 (7.2) | 24 (9.0) |
College/University or Higher | 139 (45.7) | 117 (44.0) |
Marital Status | ||
Married/Civil Union/Legal Partnership | 7 (2.3) | 3 (1.1) |
Living with Primary or Main Partner | 14 (4.6) | 16 (6.0) |
Have primary or Main Partner, not living together | 19 (6.3) | 26 (9.8) |
Single / Divorced / Widowed | 264 (86.8) | 219 (82.3) |
Other | 0 (0.0) | 2 (0.8) |
Employment Status | ||
Full or part time | 188 (61.8) | 166 (62.4) |
Not employed | 116 (38.2) | 100 (37.6) |
Household monthy income (US Dollars) 1 | ||
Median (IQR) | 482 (279, 955) | 366 (195, 698) |
CAB-LA: Cabotegravir; IQR: interquartile range; TDF/FTC: Tenofovir disoproxil fumarate/emtricitabine; TGW: transgender women.
Income of countries other than the US was converted from local currency to US Dollars using the exchange rate on Jan 1, 2017.